Flomax and Slow-k drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flomax (tamsulosin hydrochloride) and Slow-k (potassium chloride). Common drug interactions include abdominal pain among females and chronic obstructive pulmonary disease among males.

The phase IV clinical study analyzes what interactions people have when they take Flomax and Slow-k. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Flomax?

Flomax has active ingredients of tamsulosin hydrochloride. It is often used in enlarged prostate. eHealthMe is studying from 52,865 Flomax users. Check the latest studies of Flomax.

What is Slow-k?

Slow-k has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 3,683 Slow-k users. Check the latest studies of Slow-k.

On Jul, 26, 2026

12 people who take Flomax and Slow-k together, and have interactions are studied.

What are the common drug interactions of Flomax and Slow-K, by gender? *:

female:

Abdominal pain
Aphasia (damage to the parts of the brain that control language)
Coma (state of unconsciousness lasting more than six hours)
Dyspnoea (difficult or laboured respiration)
Faecal occult blood (blood clot in stool)
Pulmonary hypertensive crisis (increase in blood pressure in the lung artery-crisis)

male:

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Skin disorder (skin disease)
Oedema peripheral (superficial swelling)
Squamous cell carcinoma (a cancer of a kind of epithelial cell)
Therapeutic response decreased (less preventive response)
Blood creatinine increased
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
C-reactive protein increased
Cardiac failure congestive
Cerebral infarction (less blood supply to brain resulting tissue damage)

What are the common drug interactions of Flomax and Slow-K, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Dyspnoea (difficult or laboured respiration)
Pulmonary hypertensive crisis (increase in blood pressure in the lung artery-crisis)

50-59:

n/a

60+:

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Skin disorder (skin disease)
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
C-reactive protein increased
Cardiac failure congestive
Cerebral infarction (less blood supply to brain resulting tissue damage)
Constipation
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Haemoglobin decreased
Herpes zoster

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 16.67%
Prostate Cancer: 2 people, 16.67%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 8.33%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 8.33%
Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
Diabetes: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Flomax and Slow-k?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously